These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5772312)
41. [Research on electrolyte changes during reducing therapy of the obese]. Fekete T; Sopon E Stud Cercet Med Interna; 1972; 13(6):545-9. PubMed ID: 4657207 [No Abstract] [Full Text] [Related]
42. [Metabolic changes during complete and prolonged fasting]. Calzavara G; Lusiani GB; Gambari PF G Clin Med; 1968 Nov; 49(11):1131-50. PubMed ID: 5741976 [No Abstract] [Full Text] [Related]
43. [Intermittent total fasting in the treatment of resistent obesity]. Ortigosa Ramirez JL; Gutierrez Samperio C Prensa Med Mex; 1969; 34(5):123-8. PubMed ID: 5386321 [No Abstract] [Full Text] [Related]
44. [Treatment of obesity through total fasting]. Ditschuneit H Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1356-64. PubMed ID: 1029997 [No Abstract] [Full Text] [Related]
45. The effect of treatment on obesity. A follow-up investigation of a material treated with complete starvation. Maagoe H; Mogensen EF Dan Med Bull; 1970 Aug; 17(7):206-9. PubMed ID: 4989695 [No Abstract] [Full Text] [Related]
46. [Total caloric fasting. Metabolic studies and various complications observed in obese patients]. Brusco OJ; De Lellis RH; Lazaroni AE Prensa Med Argent; 1971 Jun; 58(16):804-12. PubMed ID: 5094408 [No Abstract] [Full Text] [Related]
47. Impairment of glomerular filtration in fasting for obesity. Edgren B; Wester PO Acta Med Scand; 1971 Nov; 190(5):389-93. PubMed ID: 5149265 [No Abstract] [Full Text] [Related]
48. Treatment of obesity by total fasting for up to 249 days. Thomson TJ; Runcie J; Miller V Lancet; 1966 Nov; 2(7471):992-6. PubMed ID: 4162668 [No Abstract] [Full Text] [Related]
49. [On hepatic repercussions of fasting therapy of obese subjects]. Fekete T; Scurtu A Med Interna (Bucur); 1970 Sep; 22(9):1057-62. PubMed ID: 5491375 [No Abstract] [Full Text] [Related]
50. [Variations of uricemia during fasting by the obese]. Fossati P; Lefebvre J; Decoulx M; Peltier JM; Linquette M Lille Med; 1968 Jan; 13(1):41-5. PubMed ID: 5744739 [No Abstract] [Full Text] [Related]
55. [Clinical picture and late results of fasting cures]. Laube H; Frank M; Köhle K; Ditschuneit H; Pfeiffer EF Verh Dtsch Ges Inn Med; 1971; 77():580-2. PubMed ID: 5155901 [No Abstract] [Full Text] [Related]
56. [Transposition of the kidney function in persons with obesity under strict fasting]. Schulz E; Schräpler P Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1477-80. PubMed ID: 1030024 [No Abstract] [Full Text] [Related]
57. [Fasting and anabolics]. Krízek V; Stĕpánek P; Sadílek L Cas Lek Cesk; 1969; 108(19):567-71. PubMed ID: 5768145 [No Abstract] [Full Text] [Related]
58. [Modifications of hydroionic equilibrium during total fasting by nondiabetic obese patients]. Fossati P; Lefebvre J; Decoulx M; Despas G; Linquette M Lille Med; 1968 Nov; 13(9):990-4. PubMed ID: 5741673 [No Abstract] [Full Text] [Related]
59. Features of a successful therapeutic fast of 382 days' duration. Stewart WK; Fleming LW Postgrad Med J; 1973 Mar; 49(569):203-9. PubMed ID: 4803438 [TBL] [Abstract][Full Text] [Related]
60. [Behavior of serum pseudocholinesterase in fasting therapy of obesity]. Fekete T; Marcu A Stud Cercet Med Interna; 1970; 11(4):301-4. PubMed ID: 5474703 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]